Modeled kidney-linked duration geometry for sildenafil is a PK→PD construct describing how absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, renal elimination geometry, and dose-scaling geometry shape the concentration–time curve, including its tail phase. “Duration” here means modeled PK→PD behavior, not real-world persistence. Absorption rate sets rising-phase steepness, absorption timing sets temporal alignment, solubility influences dissolution-driven availability, and gastric emptying shapes input arrival. Distribution loading controls early central availability, while distribution geometry and redistribution timing shape compartmental spread. Clearance and renal elimination geometry determine removal curvature, and dose-scaling geometry represents how kidney-linked input magnitudes are compared across trajectories. PD interpretation then converts concentration profiles into modeled duration geometry: threshold placement defines the interpretation window, binding sensitivity transforms concentration differences, coupling geometry shapes downstream transitions, and PD noise bands add variability. Link to speed vs duration.
Modeled renal-elimination geometry for sildenafil represents how kidney-linked clearance parameters shape the tail phase of the PK curve. Faster modeled renal elimination compresses the tail, whereas slower modeled elimination extends its geometric span. Distribution geometry determines how absorbed material spreads across compartments, and redistribution timing can create secondary concentration waves that feed the terminal phase. Clearance geometry determines the combined curvature of removal, while concentration-dependent clearance can change that curvature across different concentration regions. First-pass metabolism and CYP3A4 metabolism geometry also shape the systemic concentration curve by altering the fraction and timing of material entering systemic circulation. Bioavailability and dose-scaling geometry determine the magnitude of the modeled input before elimination is applied. Tmax and Cmax geometry define the peak coordinates from which the decline begins. These PK trajectories then supply the input curve for PD transformation into modeled duration and elimination interpretation windows. Link to elimination speed.
PD geometry shapes modeled kidney-linked duration and elimination differences by transforming concentration trajectories into interpretation coordinates. Threshold placement determines where a PK curve enters and exits the modeled PD interpretation window. Binding sensitivity determines how concentration differences become binding differences; higher modeled sensitivity can increase separation between parameter sets, while lower sensitivity can compress that separation. Coupling geometry maps binding into downstream PD signals, with shallow slopes producing broader transitions and steep slopes producing narrower transitions. PD noise bands widen or narrow the interpreted region around those transitions. Because kidney-linked sildenafil can be represented by parameter sets differing in absorption rate, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, renal elimination geometry, and Tmax/Cmax geometry, PD mapping can expand or compress modeled duration differences without asserting any real-world timing. Link to pk speed.
Absorption rate, absorption timing, solubility, gastric emptying, distribution geometry, redistribution timing, clearance, renal elimination geometry, first-pass metabolism, CYP3A4 metabolism geometry, bioavailability, and dose-scaling geometry jointly determine the PK trajectory used for kidney-linked elimination and duration modeling. Absorption parameters establish the rising phase and input timing, while distribution loading determines how quickly the modeled central compartment is populated. Distribution geometry and redistribution timing shape subsequent compartmental movement. Clearance geometry and renal elimination geometry govern the declining phase, with concentration-dependent clearance potentially changing curvature across the trajectory. First-pass and CYP3A4 geometry influence systemic input and turnover, while bioavailability scales the available fraction. Tmax and Cmax geometry identify peak coordinates, and the resulting trajectory provides the substrate for modeled PD interpretation. This framework describes parameterized concentration-time geometry rather than real-world elimination timing or duration. Link to absorption rate.
PK variability can generate distinct modeled elimination and duration windows under different kidney-linked parameter sets. Variation in absorption rate or timing changes the location and steepness of the rising phase, while solubility and gastric emptying alter the input-function shape. Differences in distribution loading, distribution geometry, and redistribution timing can shift the concentration profile before the terminal phase begins. Clearance geometry and renal elimination geometry then modify tail curvature, while concentration-dependent clearance can produce nonuniform changes across concentration ranges. First-pass metabolism, CYP3A4 metabolism geometry, and bioavailability alter the systemic trajectory supplied to the elimination model. Dose-scaling geometry changes the magnitude of the modeled input, while Tmax and Cmax geometry establish peak coordinates. When these parameters vary together, the resulting trajectories can show compressed, extended, or differently shaped modeled duration regions. These are mathematical PK trajectories, not real-world patient timelines. Link to distribution speed.
| PK Domain | Kidney Interaction | Link |
|---|---|---|
| Clearance Geometry | Tail-phase compression/extension. | elimination speed |
| Renal Elimination Geometry | Kidney-linked removal shaping. | elimination speed |
| Dose-Scaling Geometry | Duration window scaling. | speed vs duration |
Threshold placement determines where a modeled kidney-linked PK trajectory crosses into and out of a PD interpretation region. A threshold positioned at a lower concentration can cause the modeled trajectory to enter the interpretation region earlier and leave it later, while a higher threshold can narrow that geometric interval. The effect is applied to the concentration curve generated by absorption rate, absorption timing, gastric emptying, solubility, distribution geometry, clearance geometry, and renal elimination geometry. Tmax and Cmax determine the peak coordinates from which threshold crossings are measured. Dose-scaling geometry changes the concentration scale supplied to the threshold function, while concentration-dependent clearance can reshape the late-phase curve. The resulting duration and elimination coordinates therefore depend on the relationship between PK trajectory and threshold placement rather than on a real-world duration clock. PD noise bands can further broaden the modeled boundary around each crossing. Link to pd speed.
Binding sensitivity, coupling geometry, and PD noise bands determine how strongly modeled kidney-linked PK differences appear after concentration-to-effect transformation. Binding sensitivity controls the local response to concentration changes, so two PK trajectories with similar concentrations can remain close or become more separated depending on the sensitivity parameter. Coupling geometry determines how binding changes are mapped into downstream PD coordinates; shallow slopes can broaden transitions, whereas steep slopes can compress them. Noise bands introduce an interpretation range around the modeled response, potentially reducing the apparent distinction between nearby trajectories or broadening the represented region. These PD modifiers operate on PK curves shaped by renal elimination geometry, clearance geometry, distribution, redistribution, absorption timing, and dose-scaling geometry. Consequently, the same kidney-linked PK difference can produce different modeled duration or elimination geometry under different PD parameterizations. The result remains a mathematical PK→PD interpretation, without real-world timing or outcome claims. Link to pk speed.
| PD Domain | Kidney PD Interaction | Link |
|---|---|---|
| Threshold Placement | Earlier/later duration window. | onset time |
| Binding Sensitivity | Amplification/compression. | peak variability comparison |
| Coupling Geometry | Slope-driven shaping. | onset variability comparison |
Modeled kidney-linked elimination and duration differences are determined by the shape of the concentration–time trajectory and the PD transformation applied to it. Absorption rate and timing establish the rising phase, while solubility and gastric emptying shape the systemic input function. Distribution loading, distribution geometry, and redistribution timing determine compartmental movement. Clearance geometry and renal elimination geometry shape decline, while first-pass metabolism, CYP3A4 metabolism geometry, and bioavailability modify systemic exposure geometry. Dose-scaling geometry changes the modeled input magnitude, and Tmax/Cmax geometry define peak coordinates. PD threshold placement determines the interpreted entry and exit boundaries, binding sensitivity changes concentration-to-response separation, coupling geometry controls downstream slope, and PD noise bands add variability. Kidney-linked geometry therefore emerges from interacting PK and PD parameters rather than from a single renal variable.
The main PK mechanisms are absorption, distribution, metabolism, and elimination. Absorption rate and absorption timing determine how quickly the modeled input function rises, while solubility and gastric emptying influence the shape and timing of that input. Distribution loading establishes early compartmental availability, and distribution geometry plus redistribution timing shape movement between modeled compartments. Clearance geometry and renal elimination geometry determine how the concentration trajectory declines. First-pass metabolism and CYP3A4 metabolism geometry alter systemic input and metabolic turnover, while bioavailability scales the fraction. Dose-scaling geometry changes the modeled magnitude of input. Tmax and Cmax geometry describe peak coordinates, and concentration-dependent clearance can alter curvature across concentration ranges. Together, these mechanisms generate kidney-linked PK trajectories that can differ across the trajectory without representing real-world elimination or duration timing.
The principal PD mechanisms are threshold placement, binding sensitivity, coupling, and PD noise bands. Threshold placement determines which portions of a kidney-linked concentration trajectory fall inside the interpretation region. Binding sensitivity controls how concentration differences are translated into binding differences, which can change separation between trajectories. Coupling geometry then maps binding changes into downstream PD coordinates, with slope determining how sharply the modeled response changes. PD noise bands represent uncertainty around those coordinates and can broaden the interpreted region. These parameters do not alter the underlying renal PK trajectory; instead, they transform its geometry into another coordinate system. Because the input curve already reflects absorption, distribution, metabolism, clearance, and renal-elimination parameters, PD transformation can change the apparent width or separation of duration and elimination regions without asserting real-world timing or outcomes.
Modeled kidney-linked trajectories differ across parameter sets because multiple PK variables can change. Absorption rate, timing, solubility, and gastric emptying can shift the rising phase. Distribution loading, distribution geometry, and redistribution timing can alter compartmental concentrations. Clearance geometry and renal elimination geometry modify the declining phase, while concentration-dependent clearance can change curvature at different concentration levels. First-pass metabolism, CYP3A4 metabolism geometry, and bioavailability alter systemic exposure formation, and dose-scaling geometry changes the magnitude of the modeled input. Tmax and Cmax geometry provide peak coordinates. When these PK differences are passed through identical or different PD parameters, the resulting interpretation windows can change. Such differences are properties of the parameterized model and do not represent real-world kidney-function outcomes or elimination timelines.
PK→PD mapping explains kidney-linked elimination & duration differences by treating the concentration–time curve as input to an interpretation function. PK parameters establish: absorption rate and timing shape the rising phase; solubility and gastric emptying shape input formation; distribution and redistribution shape compartmental movement; and clearance, renal elimination, first-pass metabolism, CYP3A4 geometry, and concentration-dependent clearance shape decline. Bioavailability and dose-scaling geometry modify magnitude, while Tmax and Cmax define peaks. PD parameters then transform that trajectory. Threshold placement establishes modeled entry and exit points, binding sensitivity determines concentration-to-binding translation, coupling geometry shapes downstream transitions, and noise bands define interpretation spread. The resulting kidney-linked geometry reflects the interaction of PK trajectory shape with PD transformation. It is a mathematical framework rather than a statement about real-world duration, renal disease, safety, or patient outcomes.